...
首页> 外文期刊>The Indian journal of medical research >Status of adult immunity to hepatitis A virus in healthcare workers from a tertiary care hospital in north India
【24h】

Status of adult immunity to hepatitis A virus in healthcare workers from a tertiary care hospital in north India

机译:印度北部一家三级医院的医护人员对成年人甲型肝炎病毒的免疫状况

获取原文
           

摘要

Background & objectives: Humans are considered to be the principal host for hepatitis A virus (HAV) infection. In India, heterogeneous groups of susceptible individuals coexist in different regions. There has been a decline in antibody titres to HAV among young adults which may pose a major public health problem. The objective of this study was to assess the IgG anti-HAV level among healthcare workers (HCWs) in the age group of 20-60 yr and its association with the socio-demographic variables. Methods: Blood sample (2 ml) was collected under aseptic conditions from each participant followed by the preparation of serum and storing at ?20°C. ELISA-based kits were used for the determination of IgG antibodies to HAV in the human serum samples. Results: Two hundred and fifty four HCWs were enrolled. IgG anti-HAV antibodies were detected in 97.2 per cent of the samples analyzed. No differences were observed in the levels of IgG anti-HAV antibody and education, income, occupation and socio-economic classes of the HCWs. A seropositivity rate of over 90 per cent was seen amongst all the socio-economic classes. Interpretation & conclusions: High levels of IgG protective antibodies were seen among the studied HCWs, hence HAV vaccination may not be required. It will be advisable to do a cost-benefit analysis of vaccination for HAV.
机译:背景与目的:人们被认为是甲型肝炎病毒(HAV)感染的主要宿主。在印度,易感人群的异质群体在不同地区共存。年轻人中针对HAV的抗体滴度有所下降,这可能构成重大的公共卫生问题。这项研究的目的是评估20-60岁年龄组中医护人员(HCW)的IgG抗HAV水平及其与社会人口统计学变量的相关性。方法:在无菌条件下从每位参与者中采集2毫升血液样本,然后制备血清并在20°C下保存。基于ELISA的试剂盒用于测定人血清样品中抗HAV的IgG抗体。结果:招募了254名HCW。在分析的97.2%的样本中检测到IgG抗HAV抗体。 IgG抗HAV抗体的水平以及HCW的教育程度,收入,职业和社会经济状况均未发现差异。在所有社会经济阶层中,血清阳性率均超过90%。解释与结论:在研究的HCW中发现高水平的IgG保护性抗体,因此可能不需要接种HAV疫苗。建议对甲型肝炎疫苗进行成本效益分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号